JPMorgan has rated NTES-S and BILIBILI-W as Overweight due to NTES-S being its top pick in the industry, supported by a favorable 2026 P/E ratio that is 25% below its five-year average, alongside projected operating profit growth of 17% for 2026-27. KUAISHOU-W is rated as Neutral due to limited near-term catalysts.
